Schizophrenia is a serious psychiatric condition characterised by disturbances in thinking, perception, emotion, and behaviour. It is one of the most complex conditions in clinical psychiatry — in terms of diagnosis, long-term management, and the impact it has on patients and their families.
Contrary to widespread misconception, schizophrenia is not synonymous with dangerous behaviour, split personality, or inability to function. With accurate diagnosis, appropriate treatment, and sustained clinical support, many patients achieve substantial stability and maintain meaningful lives.
Positive symptoms — additions to normal experience — include hallucinations (most commonly auditory: hearing voices), delusions (fixed false beliefs, often involving persecution or grandiosity), disorganised thinking and speech, and disorganised motor behaviour.
Negative symptoms — diminishments of normal function — include reduced emotional expression, diminished motivation and goal-directed activity, reduced speech output, social withdrawal, and reduced capacity for pleasure. Negative symptoms are often the most persistent and functionally impairing aspect over the long term.
Cognitive disturbances include difficulties with working memory, attention, processing speed, and executive function — affecting the person's capacity to work, study, and manage daily life.
First-episode schizophrenia refers to the initial onset of psychotic symptoms before any prior treatment. Early and accurate intervention at this stage is associated with significantly better long-term outcomes.
Schizophrenia must be carefully distinguished from schizoaffective disorder, bipolar disorder with psychotic features, delusional disorder, and substance-induced psychotic states — distinctions that directly determine treatment.
Accurate diagnosis of schizophrenia requires systematic assessment — not a single consultation. At IsraClinic, the process includes a comprehensive psychiatric interview examining the nature, onset, and progression of symptoms; a detailed personal, family, and treatment history; psychological assessment to characterise cognitive and personality factors; neurological examination and laboratory testing to exclude organic and substance-related causes; and neuroimaging where clinically indicated.
Collegial review of the diagnostic picture precedes any treatment decision.
For patients or families seeking a second opinion on an existing diagnosis or treatment plan, IsraClinic provides independent psychiatric assessment with full written conclusions. See: Second Opinion & Expert Consultation.
Schizophrenia requires long-term clinical management. The primary goals are reduction and stabilisation of psychotic symptoms, prevention of relapse, preservation of functioning, and support for social and occupational reintegration.
Pharmacotherapy with antipsychotic medication is the cornerstone of treatment. Medication is selected individually based on the symptom profile, phase of illness, previous treatment response and tolerability, and the patient's medical profile. The clinic works with current-generation antipsychotics approved by European and American regulatory bodies. Minimising side effects while maintaining clinical effectiveness is a central consideration. Digital prescriptions are issued through the Yarpa system.
Psychotherapy has an established role alongside pharmacotherapy. Cognitive Behavior Therapy (CBT) adapted for psychosis addresses distress related to psychotic experiences and supports insight and adherence. Supportive psychotherapy provides structured clinical contact and stability. Family psychotherapy improves the patient's social environment and reduces relapse risk.
For patients with co-occurring substance use — dual diagnosis — this is addressed within the treatment plan rather than treated separately.
All treatment follows the Psychoergonomic Method — ensuring each patient's plan is built around their specific clinical presentation, not a standard protocol.
Many patients and families seek private psychiatric assessment specifically because of concerns about confidentiality — the implications of a diagnosis for employment, insurance, and social relationships. At IsraClinic, all clinical information is strictly confidential and handled in full accordance with Israeli medical privacy law.
If you or a family member are experiencing symptoms that suggest psychosis — particularly in a first episode — prompt psychiatric assessment is essential. Early intervention is associated with significantly better long-term outcomes.
If you have an existing diagnosis and are concerned about the current treatment, IsraClinic offers independent second opinion consultations with full written conclusions.
IsraClinic accepts patients for in-person consultation in Tel Aviv and online, in English, Russian and Hebrew. No referral is required.
Clinical Reviewer: Dr. Mark Zevin, MD — Senior Psychiatrist, IsraClinic | Last reviewed: 2026
Schizophrenia affects patients and families alike. If you are seeking assessment, a second opinion, or ongoing clinical support, our team is available in English, Russian and Hebrew.